In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist
- 29 December 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 294 (2-3) , 677-684
- https://doi.org/10.1016/0014-2999(95)00604-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigsBritish Journal of Pharmacology, 1995
- NK1 and NK2 receptors are similar in man and rabbitNeuropeptides, 1994
- Characterization of NK1 and NK2 tachykinin receptors in guinea‐pig and rat bronchopulmonary and vascular systemsBritish Journal of Pharmacology, 1994
- Capsaicin Increases Airflow Resistance in Guinea PigsIn Vivoby Activating both NK2and NK1Tachykinin ReceptorsAmerican Review of Respiratory Disease, 1993
- Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septideRegulatory Peptides, 1993
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992
- Neuropeptides in the Respiratory Tract: Part IAmerican Review of Respiratory Disease, 1991
- Pharmacological analysis of [3H]‐senktide binding to NK3 tachykinin receptors in guinea‐pig ileum longitudinal muscle‐myenteric plexus and cerebral cortex membranesBritish Journal of Pharmacology, 1990
- Relative potencies of neurokinins in guinea pig trachea and human bronchusEuropean Journal of Pharmacology, 1987
- Effects of peptides and non-peptides on isolated arterial smooth muscles: Role of endotheliumEuropean Journal of Pharmacology, 1985